Multiple Sclerosis Clinical Trials

Testing BMS-986368 against a placebo for multiple sclerosis spasticity

Explore this study →

There are 4 groups in this study. Groups A, B and C receive BMS-986368. Group D, the placebo group, receives Placebo.

Sites in Edmonton, Lévis and 4 more cities

Official title: A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Multiple Sclerosis Spasticity · Celgene

Comparing 4 approaches for relapsing multiple sclerosis

Explore this study →

There are 4 groups in this study. Groups A, C and D receive Remibrutinib oral treatment. Group B, the comparison group, receives Ocrelizumab.

Sites in Edmonton, Lévis and 2 more cities

Official title: Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

Relapsing Multiple Sclerosis · Novartis Pharmaceuticals

Testing Remibrutinib (blinded) with Remibrutinib (Open label) against a placebo for secondary progressive multiple sclerosis (SPMS)

Explore this study →

There are 2 groups in this study. Group A receives one or more of: Remibrutinib (blinded) and Remibrutinib (Open label). Group B, the placebo group, receives Placebo, together with one or more of: Remibrutinib (Open label).

Sites in Montreal, Burnaby and 8 more cities

Official title: A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis (SPMS) · Novartis Pharmaceuticals

Comparing THC with CBD for multiple sclerosis

Explore this study →

There are 2 groups in this study. Group A receives THC. Group B receives CBD.

2 sites in Calgary

Official title: Cannabis (THC vs. CBD) in Multiple Sclerosis

Multiple Sclerosis · University of Calgary

Comparing 3 approaches for multiple sclerosis (MS)

Explore this study →

There are 3 groups in this study. Groups A, B and C receive one or more of: Metformin and Placebo.

One site, in Toronto

Official title: A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis

Multiple Sclerosis (MS) · The Hospital for Sick Children

Comparing 4 approaches for multiple sclerosis

Explore this study →

There are 4 groups in this study. Group A receives RO7121932 IV. Groups B and C receive RO7121932 SC. Group D receives one or more of: RO7121932 IV and RO7121932 SC.

One site, in Montreal

Official title: A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis

Multiple Sclerosis · Hoffmann-La Roche

Cannabis as a Complementary Treatment in Multiple Sclerosis

Explore this study →

There are 4 groups in this study. Groups A, B and C receive Cannabis oil vs placebo. Group D, the placebo group, receives Cannabis oil vs placebo.

One site, in Montreal

Multiple Sclerosis · Centre hospitalier de l'Université de Montréal (CHUM)